Bioinformatics and systems-biology approach to identify common pathogenic mechanisms for COVID-19 and systemic lupus erythematosus
CONCLUSION: COVID-19 and SLE patients share many common hub genes, related pathways and regulatory networks. Based on these common targets, we found many potential drugs that could be used in treating patient with COVID-19 or COVID-19 combined with SLE.PMID:38332666 | DOI:10.1080/08916934.2024.2304826
Source: Autoimmunity - Category: Allergy & Immunology Authors: Yinlan Wu Yanhong Li Yu Zhou Xiufeng Bai Yi Liu Source Type: research
More News: Allergy & Immunology | Biology | Coronavirus | COVID-19 | Genetics | Lupus | Pandemics | Study